Volume | 0 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Surrozen Inc | SRZNW | NASDAQ | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0181 | 0.0181 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 0.0181 | USD |
Surrozen Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
553.41k | 30.58M | - | 0 | -43.04M | -1.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Surrozen
Date | Time | Source | Heading |
---|---|---|---|
11/06/2024 | 15:13 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/06/2024 | 08:07 | Edgar (US Regulatory) | Form 8-K - Current report |
11/01/2024 | 11:42 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
10/02/2024 | 15:28 | Edgar (US Regulatory) | Form 8-K - Current report |
6/18/2024 | 18:44 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
6/07/2024 | 15:35 | Edgar (US Regulatory) | Form 8-K - Current report |
6/06/2024 | 19:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
6/06/2024 | 19:26 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
5/08/2024 | 15:18 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
5/08/2024 | 15:12 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
SRZNW Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). |